Understanding the rationale for metronidazole use in dogs and cats
Journal of Small Animal Practice · 2025
DOI: 10.1111/jsap.13910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Small Animal Practice, 2025. Verfasst von J Ng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Davies Veterinary Specialists, part of Linnaeus Veterinary Limited, Higham Gobion, UK. Hauptthemen laut MEDLINE: Metronidazole, Dog Diseases, Cat Diseases, Anti-Infective Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Linnaeus Veterinary Limited, Small Animal Medicine Society.
Abstract (Originalsprache)
Objective
It is currently unknown how often antibiotics (including metronidazole) are used for non‐antibacterial purposes in dogs and cats. This study looked to characterise the rationale for metronidazole prescription in these species.
Methods
Retrospective cohort study. Veterinarians reported clinical information for dogs and cats treated with metronidazole in the previous year, including the rationale for metronidazole selection.
Results
Three hundred and thirty‐two cases were reported by 138 veterinarians describing metronidazole use in 47 cats and 285 dogs. Metronidazole was most commonly prescribed to treat acute diarrhoea ( n = 156, 47%), chronic diarrhoea ( n = 79, 24%) or giardiasis ( n = 36, 11%). Veterinarians selected metronidazole exclusively for non‐antimicrobial targeted therapy in 42% of cases (125/300). Putative anti‐inflammatory/immunomodulatory properties were cited in 64% of cases (213/332). Educational resources (41/92, 45%), team‐based collaboration (29/92, 32%) and specialist consultation (10/92, 11%) were cited as the supportive basis for these prescription choices. Clinical significance Veterinarians are using metronidazole frequently for non‐antimicrobial properties in contradiction to antimicrobial use guidelines. Future stewardship programs should adapt guidance specifically to counter this prescribing behaviour.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Davies Veterinary Specialists, part of Linnaeus Veterinary Limited, Higham Gobion, UK.
- Department of Internal Medicine, Willows Veterinary Centre & Referral Service, Solihull, UK.
- Department of Small Animal Medicine and Surgery, University of Veterinary Medicine, Hannover, Foundation, Hannover, Germany.
- Mars Veterinary Health, Vancouver, Washington, USA.
- Centre for Public Health and Zoonoses, Ontario Veterinary College - University of Guelph, Guelph, Ontario, Canada.
- Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Neston, UK.
Förderung
- Linnaeus Veterinary Limited
- Small Animal Medicine Society
Zitieren
APA
Ng, J., Steffensen, N., Battersby, I., Weese, J. S., Timofte, D., Toutain, P. L., Granick, J. L., Elliott, J., Choi, S., Sparks, T., Tavener, S., & Allerton, F. (2025). Understanding the rationale for metronidazole use in dogs and cats. Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13910
Vancouver
Ng J, Steffensen N, Battersby I, Weese JS, Timofte D, Toutain PL, et al. Understanding the rationale for metronidazole use in dogs and cats. Journal of Small Animal Practice. 2025. doi:10.1111/jsap.13910
BibTeX
@article{Ng2025,
author = {Ng, J and Steffensen, N and Battersby, I and Weese, J S and Timofte, D and Toutain, P L and Granick, J L and Elliott, J and Choi, S and Sparks, T and Tavener, S and Allerton, F},
title = {Understanding the rationale for metronidazole use in dogs and cats},
journal = {Journal of Small Animal Practice},
year = {2025},
doi = {10.1111/jsap.13910}
}
EUVIMED